4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one

Catalog No.: 
ACXRWQ467
CAS No.: 
100818-32-4
Molecular Formula: 
C10H19BO3
Molecular Weight: 
198.07
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$121.00InquiryInquiry
1g95%$261.00InquiryInquiry
5g95%$742.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one
MDL No.MFCD22208512
Molecular FormulaC10H19BO3
Molecular Weight198.07
SMILESCC(CCB1OC(C)(C)C(C)(C)O1)=O
InChI KeyLKTYRLPRDAUIDH-UHFFFAOYSA-N
Synonym4-(TetraMethyl-1,3,2-dioxaborolan-2-yl)butan-2-one;2-Butanone, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;TB-2486
CAS No.100818-32-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P312-P322-P330-P363-P501

Synthetic Route by SureRoute

1. ACXRWQ467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZLSV654 route compound structure diagram
    ACZLSV65428509-46-8
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  4. Then
  5. ACXRWQ467 route product structure diagram
    ACXRWQ467100818-32-4
Inquiry

2. ACXRWQ467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXRWQ467 route product structure diagram
    ACXRWQ467100818-32-4
Inquiry

3. ACXRWQ467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXRWQ467 route product structure diagram
    ACXRWQ467100818-32-4
Inquiry

Comments (0)